Research alliance will advance small-molecule therapy for most common form of acute leukemia, targeting proteins involved in transcriptional regulation.

With subtypes now defined, future studies could reveal previously unknown contributions of the serotonergic neuronal system to disease, inform the development of biomarkers, or lead to more targeted therapies.

Accelerator supports Harvard faculty in conducting and developing applied life science research.

A molecule isolated from sea sponges and synthesized at Harvard can halt the growth of cancerous cells.